Select Page

Health Archive

CSOFT’s health sciences blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.

Home 9 Health 9 ArchivePage 32
FDA Issues EUA for Vela Diagnostics Covid  PCR Test

FDA Issues EUA for Vela Diagnostics Covid PCR Test

The FDA issued yesterday (8/5) Emergency Use Authorization for Vela Diagnostics for the manual version of their Covid PCR test. The manual version of the test enables flexible sample processing, facilitating widespread use of the test throughout the United States. Sam...

Covid Potential for Brain Damage, According to Scientists

Covid Potential for Brain Damage, According to Scientists

A study conducted by researchers at University College London (UCL) reported 43 cases of patients diagnosed with Covid experiencing temporary brain damage. The scientists warned that new evidence suggests potential issues of severe neurological complications, like...

Early Potential in Human Trials for Covid Vaccine

Early Potential in Human Trials for Covid Vaccine

BioNTech, and Pfizer have partnered to produce one of the 17 Covid vaccines currently in development. The vaccine has shown promising early-stage human trials among 24 participants, alongside other pharmaceutical companies like Moderna, Inovio Pharmaceuticals,...

Gilead Sets Price for Covid Treatment Remdesivir

Gilead Sets Price for Covid Treatment Remdesivir

Gilead Sciences, the biotech company based out of California that created one of the first original treatments for Covid, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...